NCT06638931 2025-05-28ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Active not recruiting28 enrolled
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT00526149 2013-10-07BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Completed76 enrolled